renal cell carcinoma gene therapy (Targa Therapies)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerenal cell carcinoma gene therapy (Targa Therapies)
Drug Alias NameADS-based gene therapy (Targa Therapies)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTarga Therapies SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTarga Therapies SA
Active IndicationsN/A
Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A